Shanghai Rightongene Net Income vs. EBITDA

688217 Stock   20.89  0.14  0.67%   
Based on the measurements of profitability obtained from Shanghai Rightongene's financial statements, Shanghai Rightongene Biotechnology may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Shanghai Rightongene's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
2010-12-31
Previous Quarter
7.9 M
Current Value
7.5 M
Quarterly Volatility
10.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
For Shanghai Rightongene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shanghai Rightongene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shanghai Rightongene Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shanghai Rightongene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shanghai Rightongene Biotechnology over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Shanghai Rightongene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shanghai Rightongene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shanghai Rightongene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Shanghai Rightongene EBITDA vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Rightongene's current stock value. Our valuation model uses many indicators to compare Shanghai Rightongene value to that of its competitors to determine the firm's financial worth.
Shanghai Rightongene Biotechnology is number one stock in net income category among its peers. It also is number one stock in ebitda category among its peers totaling about  3.27  of EBITDA per Net Income. At present, Shanghai Rightongene's Net Income is projected to decrease significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Rightongene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Rightongene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Shanghai EBITDA vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Shanghai Rightongene

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
7.93 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Shanghai Rightongene

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
25.94 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Shanghai EBITDA Comparison

Shanghai Rightongene is currently under evaluation in ebitda category among its peers.

Shanghai Rightongene Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Shanghai Rightongene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shanghai Rightongene will eventually generate negative long term returns. The profitability progress is the general direction of Shanghai Rightongene's change in net profit over the period of time. It can combine multiple indicators of Shanghai Rightongene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income2.9 M2.2 M
Interest Income3.8 M2.8 M
Operating Income352.3 K334.7 K
Net Loss-4.8 M-4.6 M
Income Before Tax-9.4 M-8.9 M
Net Income7.9 M7.5 M

Shanghai Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Shanghai Rightongene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shanghai Rightongene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shanghai Rightongene's important profitability drivers and their relationship over time.

Use Shanghai Rightongene in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shanghai Rightongene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rightongene will appreciate offsetting losses from the drop in the long position's value.

Shanghai Rightongene Pair Trading

Shanghai Rightongene Biotechnology Pair Trading Analysis

The ability to find closely correlated positions to Shanghai Rightongene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai Rightongene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai Rightongene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai Rightongene Biotechnology to buy it.
The correlation of Shanghai Rightongene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shanghai Rightongene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shanghai Rightongene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shanghai Rightongene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Shanghai Rightongene position

In addition to having Shanghai Rightongene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Personal Services Thematic Idea Now

Personal Services
Personal Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Personal Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Personal Services Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Shanghai Stock

To fully project Shanghai Rightongene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shanghai Rightongene at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shanghai Rightongene's income statement, its balance sheet, and the statement of cash flows.
Potential Shanghai Rightongene investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Shanghai Rightongene investors may work on each financial statement separately, they are all related. The changes in Shanghai Rightongene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Shanghai Rightongene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.